A
Achilles Therapeutics PLC
NASDAQ:ACHL
Achilles Therapeutics PLC
NASDAQ:ACHL
Price:
1.48
USD
0.68%
Market Closed
Market Cap:
$60.8m
Income Statement
Earnings Waterfall
Achilles Therapeutics PLC
Achilles Therapeutics PLC
Income Statement
Achilles Therapeutics PLC
Achilles Therapeutics PLC
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(34)
|
(35)
|
(51)
|
(59)
|
(64)
|
(69)
|
(73)
|
(74)
|
(78)
|
(78)
|
(76)
|
(79)
|
(75)
|
(71)
|
(71)
|
(72)
|
|
| Selling, General & Administrative |
(11)
|
(12)
|
(17)
|
(19)
|
(22)
|
(23)
|
(23)
|
(24)
|
(21)
|
(20)
|
(18)
|
(17)
|
(17)
|
(16)
|
(16)
|
(16)
|
|
| Research & Development |
(23)
|
(23)
|
(34)
|
(39)
|
(42)
|
(46)
|
(50)
|
(50)
|
(57)
|
(58)
|
(57)
|
(61)
|
(58)
|
(55)
|
(54)
|
(56)
|
|
| Operating Income |
(34)
N/A
|
(35)
-4%
|
(51)
-47%
|
(59)
-15%
|
(64)
-9%
|
(69)
-8%
|
(73)
-5%
|
(74)
0%
|
(78)
-6%
|
(78)
0%
|
(76)
+3%
|
(79)
-4%
|
(75)
+4%
|
(71)
+6%
|
(71)
+0%
|
(72)
-2%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
0
|
0
|
(0)
|
2
|
3
|
4
|
6
|
6
|
4
|
2
|
(1)
|
(2)
|
(1)
|
0
|
1
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
4
|
5
|
6
|
6
|
7
|
7
|
6
|
7
|
|
| Pre-Tax Income |
(33)
N/A
|
(35)
-5%
|
(51)
-46%
|
(56)
-9%
|
(61)
-10%
|
(65)
-6%
|
(66)
-2%
|
(65)
+1%
|
(71)
-9%
|
(71)
0%
|
(71)
+1%
|
(75)
-6%
|
(69)
+8%
|
(64)
+7%
|
(64)
+1%
|
(66)
-5%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(33)
|
(35)
|
(51)
|
(56)
|
(61)
|
(65)
|
(66)
|
(65)
|
(71)
|
(71)
|
(71)
|
(75)
|
(70)
|
(64)
|
(64)
|
(67)
|
|
| Net Income (Common) |
(33)
N/A
|
(35)
-5%
|
(51)
-46%
|
(56)
-9%
|
(61)
-9%
|
(65)
-6%
|
(66)
-2%
|
(65)
+1%
|
(71)
-9%
|
(71)
0%
|
(71)
+1%
|
(75)
-6%
|
(70)
+7%
|
(64)
+8%
|
(64)
+1%
|
(67)
-5%
|
|
| EPS (Diluted) |
-0.82
N/A
|
-0.86
-5%
|
-1.43
-66%
|
-1.45
-1%
|
-2.13
-47%
|
-1.66
+22%
|
-1.7
-2%
|
-1.68
+1%
|
-1.82
-8%
|
-1.81
+1%
|
-1.79
+1%
|
-1.89
-6%
|
-1.74
+8%
|
-1.6
+8%
|
-1.59
+1%
|
-1.66
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
